226 related articles for article (PubMed ID: 37198626)
1. Clinicopathological correlation of Cathepsin K expression in salivary gland carcinomas; relation to patients` outcome.
Elhendawy HA; Soliman S
Diagn Pathol; 2023 May; 18(1):66. PubMed ID: 37198626
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of heat shock protein 70 in oral carcinogenesis and prediction of progression and recurrence in oral squamous cell carcinoma patients: a retrospective clinicopathological study.
Elhendawy HA
Eur J Med Res; 2023 Oct; 28(1):464. PubMed ID: 37884988
[TBL] [Abstract][Full Text] [Related]
3. Concomitant expression of ezrin and HER2 predicts distant metastasis and poor prognosis of patients with salivary gland carcinomas.
Hashimoto K; Hayashi R; Mukaigawa T; Yamazaki M; Fujii S
Hum Pathol; 2017 May; 63():110-119. PubMed ID: 28300573
[TBL] [Abstract][Full Text] [Related]
4. Podoplanin expression in salivary gland carcinomas and its clinical significance. An immunohistochemical study.
Soliman S; Elsherbeny MF; Sheta H; Mohamed AS; Fawzy MM; Sakr DH; Lotfy N
Pol J Pathol; 2022; 73(4):320-329. PubMed ID: 36946268
[TBL] [Abstract][Full Text] [Related]
5. Survival Outcome of Salivary Gland Carcinoma: A 50-Year Retrospective Study With Long-Term Follow-up.
Jia MQ; Gao M; Ye P; Gao Y; Yu GY; Wang HH; Peng X
J Oral Maxillofac Surg; 2022 Dec; 80(12):2003-2014. PubMed ID: 36100114
[TBL] [Abstract][Full Text] [Related]
6. Expression of TMPRSS4 in patients with salivary adenoid cystic carcinoma: correlation with clinicopathological features and prognosis.
Dai W; Zhou Q; Xu Z; Zhang E
Med Oncol; 2013 Dec; 30(4):749. PubMed ID: 24132607
[TBL] [Abstract][Full Text] [Related]
7. A nomogram involving immune-inflammation index for predicting distant metastasis-free survival of major salivary gland carcinoma following postoperative radiotherapy.
Yan W; Ou X; Shen C; Hu C
Cancer Med; 2023 Feb; 12(3):2772-2781. PubMed ID: 36052414
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of CD8-positive tumour-infiltrating lymphocytes and PD-L1 expression in salivary gland cancer.
Kesar N; Winkelmann R; Oppermann J; Ghanaati S; Martin D; Neumayer T; Balster S; Rödel C; Rödel F; von der Grün J; Balermpas P
Oral Oncol; 2020 Dec; 111():104931. PubMed ID: 32736208
[TBL] [Abstract][Full Text] [Related]
10. Programmed death ligand-1 expression is associated with poor disease free survival in salivary gland carcinomas.
Mukaigawa T; Hayashi R; Hashimoto K; Ugumori T; Hato N; Fujii S
J Surg Oncol; 2016 Jul; 114(1):36-43. PubMed ID: 27111278
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Cancer Stem Cell Markers in Patients With Salivary Gland Carcinomas.
Sadeghi H; Saffar H; Taheri P; Yazdani F; Etebarian A
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):284-290. PubMed ID: 35001035
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment quantitative
Gencturk M; Ozturk K; Koksel Y; Li F; Cayci Z
Clin Imaging; 2019; 53():17-24. PubMed ID: 30308429
[TBL] [Abstract][Full Text] [Related]
13. Ten year experience with surgery and radiation in the management of malignant major salivary gland tumors.
Iqbal H; Bhatti AB; Hussain R; Jamshed A
Asian Pac J Cancer Prev; 2014; 15(5):2195-9. PubMed ID: 24716956
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of immunohistochemistry in salivary gland cancer].
Ettl T; Schwarz S; Kühnel T; Stockmann P; Reichert TE; Driemel O
HNO; 2008 Feb; 56(2):231-8. PubMed ID: 18214402
[TBL] [Abstract][Full Text] [Related]
15. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
[TBL] [Abstract][Full Text] [Related]
16. The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype.
Linxweiler M; Kuo F; Katabi N; Lee M; Nadeem Z; Dalin MG; Makarov V; Chowell D; Dogan S; Ganly I; Hakimi AA; Wong RJ; Riaz N; Ho AL; Chan TA; Morris LGT
Clin Cancer Res; 2020 Jun; 26(12):2859-2870. PubMed ID: 32060100
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte activation gene 3 (LAG3) protein expression on tumor-infiltrating lymphocytes in aggressive and TP53-mutated salivary gland carcinomas.
Arolt C; Meyer M; Ruesseler V; Nachtsheim L; Wuerdemann N; Dreyer T; Gattenlöhner S; Wittekindt C; Buettner R; Quaas A; Klussmann JP
Cancer Immunol Immunother; 2020 Jul; 69(7):1363-1373. PubMed ID: 32232506
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Role of miRNAs in Salivary Gland Carcinomas: From Biomarkers to Therapeutic Targets.
Kimura TC; de Lima-Souza RA; Maciel TF; Kowalski LP; Coutinho-Camillo CM; Egal ESA; Altemani A; Mariano FV
Head Neck Pathol; 2024 Feb; 18(1):12. PubMed ID: 38393615
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy.
Liu G; Zheng H; Zhang Z; Wu Z; Xiong H; Li J; Song L
BMC Cancer; 2010 Sep; 10():495. PubMed ID: 20846391
[TBL] [Abstract][Full Text] [Related]
20. [Tumor microenvironment in salivary gland carcinomas: Consequences for new therapeutic concepts].
Meyer MF; Arolt C; Kansy BA; Doescher J; Quaas A; Beutner D; Lang S; Klußmann JP
HNO; 2020 Dec; 68(12):927-934. PubMed ID: 32929519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
